Drs Ursula A. Matulonis and Leif W. Ellisen discuss endometrial cancer and ADCs, including resistance mechanisms, ADC sequencing, what's exciting in the field, and novel payloads.

An Arkansas woman is sharing her story of becoming a new mom and beating the odds while fighting uterine cancer.

The study will be carried out in partnership with The GOG Foundation and the European Network of Gynaecological Oncological ...

For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and maintenance of quality of life.

June is uterine cancer awareness month, one of the few cancers with a rising death rate in the U.S and researchers are working<a class="excerpt-read-more" href=" More ...

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...

In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 ...

The study, published earlier this year in the Proceedings of the National Academy of Sciences, examined how abnormal cells ...